These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9160622)

  • 1. Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder.
    Nair NP; Bakish D; Saxena B; Amin M; Schwartz G; West TE
    Anxiety; 1996; 2(4):192-8. PubMed ID: 9160622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.
    Bakish D; Hooper CL; Filteau MJ; Charbonneau Y; Fraser G; West DL; Thibaudeau C; Raine D
    Psychopharmacol Bull; 1996; 32(1):135-41. PubMed ID: 8927663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients.
    Fabre L; Birkhimer LJ; Zaborny BA; Wong LF; Kapik BM
    Int Clin Psychopharmacol; 1996 Jun; 11(2):119-27. PubMed ID: 8803649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
    Claghorn JL; Earl CQ; Walczak DD; Stoner KA; Wong LF; Kanter D; Houser VP
    J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 15-year follow-up study of patients with panic disorder.
    Andersch S; Hetta J
    Eur Psychiatry; 2003 Dec; 18(8):401-8. PubMed ID: 14680716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sertraline versus imipramine treatment of comorbid panic disorder and major depressive disorder.
    Lepola U; Arató M; Zhu Y; Austin C
    J Clin Psychiatry; 2003 Jun; 64(6):654-62. PubMed ID: 12823079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients.
    Asnis GM; Hameedi FA; Goddard AW; Potkin SG; Black D; Jameel M; Desagani K; Woods SW
    Psychiatry Res; 2001 Aug; 103(1):1-14. PubMed ID: 11472786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvoxamine or placebo in the treatment of panic disorder and relationship to blood concentrations of fluvoxamine.
    Sandmann J; Lörch B; Bandelow B; Härtter S; Winter P; Hiemke C; Benkert O
    Pharmacopsychiatry; 1998 Jul; 31(4):117-21. PubMed ID: 9754844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis.
    Boyer W
    Int Clin Psychopharmacol; 1995 Mar; 10(1):45-9. PubMed ID: 7622804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactate-induced anxiety after imipramine and diazepam treatment.
    Pohl R; Balon R; Berchou R; Lycaki H
    Anxiety; 1994; 1(2):54-63. PubMed ID: 9160549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo.
    Sheikh JI; Swales PJ
    Int J Psychiatry Med; 1999; 29(1):107-17. PubMed ID: 10376237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients.
    van den Broek WW; Birkenhäger TK; Mulder PG; Bruijn JA; Moleman P
    Psychopharmacology (Berl); 2004 Oct; 175(4):481-6. PubMed ID: 15243735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind comparative study of brofaromine and fluvoxamine in outpatients with panic disorder.
    van Vliet IM; den Boer JA; Westenberg HG; Slaap BR
    J Clin Psychopharmacol; 1996 Aug; 16(4):299-306. PubMed ID: 8835705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipramine vs. sertraline in panic disorder: 24-week treatment completers.
    Mavissakalian MR
    Ann Clin Psychiatry; 2003; 15(3-4):171-80. PubMed ID: 14971862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panic disorder.
    Kumar S; Oakley-Browne M
    Clin Evid; 2002 Jun; (7):906-12. PubMed ID: 12230714
    [No Abstract]   [Full Text] [Related]  

  • 16. Panic disorder: long-term pharmacotherapy and discontinuation.
    Rickels K; Schweizer E
    J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):12S-18S. PubMed ID: 9872708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fluvoxamine on panic disorder.
    Hoehn-Saric R; McLeod DR; Hipsley PA
    J Clin Psychopharmacol; 1993 Oct; 13(5):321-6. PubMed ID: 8227490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A naturalistic 6-year follow-up study of patients with panic disorder.
    Lepola U; Koponen H; Leinonen E
    Acta Psychiatr Scand; 1996 Mar; 93(3):181-3. PubMed ID: 8739663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growing placebo response rate: the problem in recent therapeutic trials?
    Uhlenhuth EH; Matuzas W; Warner TD; Thompson PM
    Psychopharmacol Bull; 1997; 33(1):31-9. PubMed ID: 9133749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Panic disorder.
    Kumar S; Oakley-Browne M
    Clin Evid; 2002 Dec; (8):1003-9. PubMed ID: 12603925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.